Primary care detection of Alzheimer’s disease using a self-administered digital cognitive test and blood biomarkers

Primary care detection of Alzheimer’s disease using a self-administered digital cognitive test and blood biomarkers

After the clinical implementation of amyloid-β-targeting therapies for people with cognitive impairment due to Alzheimer’s disease (AD), there is an urgent need to efficiently identify this patient population in primary care. Therefore, we created a brief and self-administered digital cognitive test battery (BioCog). Based on its sub-scores, a logistic regression model was developed in a secondary care cohort (n = 223) and then evaluated in an i…

Researchers are creating digital self-assessment tools for diagnosing Alzheimer's disease.

A recent proof-of-concept study conducted by researchers at Lund University reveals that a brief self-management digital cognitive assessment called BioCog effectively detects cognitive impairments. When used alongside blood tests, it can accurately identify clinical Alzheimer’s disease in primary care settings. In primary care, the BioCog test achieved 85% accuracy in identifying cognitive impairments with a [...] The post Researchers are creat…